Related references
Note: Only part of the references are listed.Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses
Jacob C. Milligan et al.
CELL (2022)
Pan-ebolavirus protective therapy by two multifunctional human antibodies
Pavlo Gilchuk et al.
CELL (2021)
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus
Bronwyn M. Gunn et al.
IMMUNITY (2021)
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
Andrew J. Pollard et al.
LANCET INFECTIOUS DISEASES (2021)
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
Charles D. Murin et al.
CELL REPORTS (2021)
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
Kathryn M. Hastie et al.
SCIENCE (2021)
Structural Basis for a Convergent Immune Response against Ebola Virus
Hadas Cohen-Dvashi et al.
CELL HOST & MICROBE (2020)
Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions
Bache Emmanuel Bache et al.
FUTURE MICROBIOLOGY (2020)
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Pavlo Gilchuk et al.
IMMUNITY (2020)
Development of an antibody cocktail for treatment of Sudan virus infection
Andrew S. Herbert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A Vaccine against Ebola Virus
Erica Ollmann Saphire
CELL (2020)
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies
Philipp A. Ilinykh et al.
CELL HOST & MICROBE (2020)
Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition
Jason Gorman et al.
CELL REPORTS (2020)
Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors
Pengfei Fan et al.
MABS (2020)
Structural Characterization of Pan-Ebolavirus Antibody 6D6 Targeting the Fusion Peptide of the Surface Glycoprotein
Jacob C. Milligan et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Structural basis of broad ebolavirus neutralization by a human survivor antibody
Brandyn R. West et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
Achieving cross-reactivity with pan-ebolavirus antibodies
Liam B. King et al.
CURRENT OPINION IN VIROLOGY (2019)
Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection
Carl W. Davis et al.
CELL (2019)
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans
Pramila Rijal et al.
CELL REPORTS (2019)
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
Liam B. King et al.
NATURE COMMUNICATIONS (2019)
Differential requirements for FcγR engagement by protective antibodies against Ebola virus
Stylianos Bournazos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
Stefanie A. Ehrhardt et al.
NATURE MEDICINE (2019)
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates
Zachary A. Bornholdt et al.
CELL HOST & MICROBE (2019)
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection
Anna Z. Wec et al.
CELL HOST & MICROBE (2019)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
Jennifer M. Brannan et al.
NATURE COMMUNICATIONS (2019)
Characterization of a filovirus (Mengla virus) from Rousettus bats in China
Xing-Lou Yang et al.
NATURE MICROBIOLOGY (2019)
The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding
Liam B. King et al.
CELL HOST & MICROBE (2018)
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
Kristen E. Pascal et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
The evolutionary history of vertebrate RNA viruses
Mang Shi et al.
NATURE (2018)
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region
Andrew I. Flyak et al.
NATURE MICROBIOLOGY (2018)
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Erica Ollmann Saphire et al.
CELL (2018)
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M. Gunn et al.
CELL HOST & MICROBE (2018)
Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope
Brandyn R. West et al.
MBIO (2018)
Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
Benjamin M. Janus et al.
NATURE COMMUNICATIONS (2018)
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)
Ana Maria Henao-Restrepo et al.
LANCET (2017)
Structure of the Ebola virus glycoprotein spike within the virion envelope at 11Å resolution
Daniel Beniac et al.
SCIENTIFIC REPORTS (2017)
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses
Anna Z. Wec et al.
CELL (2017)
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability
Xuelian Zhao et al.
CELL (2017)
Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein
Zhen-Yong Keck et al.
JOURNAL OF VIROLOGY (2016)
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection
Andrew I. Flyak et al.
CELL (2016)
Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1
Han Wang et al.
CELL (2016)
Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies
Philipp A. Ilinykh et al.
JOURNAL OF VIROLOGY (2016)
Toremifene interacts with and destabilizes the Ebola virus glycoprotein
Yuguang Zhao et al.
NATURE (2016)
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
Richard T. Davey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Trojan horse bispecific-antibody strategy for broad protection against ebolaviruses
Anna Z. Wec et al.
SCIENCE (2016)
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Davide Corti et al.
SCIENCE (2016)
Structural and molecular basis for Ebola virus neutralization by protective human antibodies
John Misasi et al.
SCIENCE (2016)
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak
Zachary A. Bornholdt et al.
SCIENCE (2016)
Progression of Ebola Therapeutics During the 2014-2015 Outbreak
Emelissa J. Mendoza et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Potent neutralizing monoclonal antibodies against Ebola virus infection
Qi Zhang et al.
SCIENTIFIC REPORTS (2016)
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
Katie A. Howell et al.
CELL REPORTS (2016)
Structures of Ebola virus GP and sGP in complex with therapeutic antibodies
Jesper Pallesen et al.
NATURE MICROBIOLOGY (2016)
Discovery of an antibody for pan-ebolavirus therapy
Wakako Furuyama et al.
SCIENTIFIC REPORTS (2016)
Structural Basis for Marburg Virus Neutralization by a Cross-Reactive Human Antibody
Takao Hashiguchi et al.
CELL (2015)
Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus
Andrew I. Flyak et al.
CELL (2015)
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies
Edgar Davidson et al.
JOURNAL OF VIROLOGY (2015)
The Multiple Roles of sGP in Ebola Pathogenesis
Marc-Antoine de La Vega et al.
VIRAL IMMUNOLOGY (2015)
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Xiangguo Qiu et al.
NATURE (2014)
Clinical Care of Two Patients with Ebola Virus Disease in the United States
G. Marshall Lyon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Second Generation Inactivated Eastern Equine Encephalitis Virus Vaccine Candidates Protect Mice against a Lethal Aerosol Challenge
Shelley P. Honnold et al.
PLOS ONE (2014)
Structures of protective antibodies reveal sites of vulnerability on Ebola virus
Charles D. Murin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1
Melinda Ng et al.
VIROLOGY (2014)
Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool
Yingda Xu et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2013)
Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus
Daniel Olal et al.
JOURNAL OF VIROLOGY (2012)
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
Gene Garrard Olinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
Xiangguo Qiu et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Forty-Five Years of Marburg Virus Research
Kristina Brauburger et al.
VIRUSES-BASEL (2012)
Clinical aspects of Marburg hemorrhagic fever
Masfique Mehedi et al.
FUTURE VIROLOGY (2011)
Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis
Paulina Aleksandrowicz et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A shared structural solution for neutralizing ebolaviruses
Joao M. Dias et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
A Forward Genetic Strategy Reveals Destabilizing Mutations in the Ebolavirus Glycoprotein That Alter Its Protease Dependence during Cell Entry
Anthony C. Wong et al.
JOURNAL OF VIROLOGY (2010)
Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes
Mohammad F. Saeed et al.
PLOS PATHOGENS (2010)
Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner
Asuka Nanbo et al.
PLOS PATHOGENS (2010)
Ebolavirus glycoprotein structure and mechanism of entry
Jeffrey E. Lee et al.
FUTURE VIROLOGY (2009)
The Primed Ebolavirus Glycoprotein (19-Kilodalton GP1,2): Sequence and Residues Critical for Host Cell Binding
Derek Dube et al.
JOURNAL OF VIROLOGY (2009)
Complex of a protective antibody with its Ebola virus GP peptide epitope:: Unusual features of a Vλx light chain
Jeffrey E. Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Jeffrey E. Lee et al.
NATURE (2008)
Generation of biologically contained Ebola viruses
Peter Halfmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity
Rachel L. Kaletsky et al.
JOURNAL OF VIROLOGY (2007)
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys
Wendelien B. Oswald et al.
PLOS PATHOGENS (2007)
Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein
K Schornberg et al.
JOURNAL OF VIROLOGY (2006)
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection
K Chandran et al.
SCIENCE (2005)
Epitopes involved in antibody-mediated protection from Ebola virus
JA Wilson et al.
SCIENCE (2000)
Proteolytic processing of Marburg virus glycoprotein
VE Volchkov et al.
VIROLOGY (2000)
Share Paper
